{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:36:57Z","timestamp":1788482217497,"version":"build-2803163510"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:00:00Z","timestamp":1738108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:00:00Z","timestamp":1738108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFE0204500"],"award-info":[{"award-number":["2023YFE0204500"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272856"],"award-info":[{"award-number":["82272856"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2022A1515010437"],"award-info":[{"award-number":["2022A1515010437"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"name":"President\u2019s Foundation of the Third Affiliated Hospital of Southern Medical University","award":["YM2021010"],"award-info":[{"award-number":["YM2021010"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Prostate cancer (PCa) is a highly common type of malignancy and affects millions of men in the world since it is easy to recur or emerge therapy resistance. Therefore, it is urgent to find novel treatments for PCa patients. In the current study, we found that tegaserod maleate (TM), an FDA-approved agent, inhibited proliferation, colony formation, migration as well as invasion, caused the arrest of the\u00a0cell cycle, and promoted apoptosis of PCa cells in vitro. In addition, TM suppressed the tumor growth in the cell-derived xenograft (CDX) mouse model in vivo. Mechanistically, TM exerted anti-tumor effects via downregulating GLI2,\u00a0and its downtream\u00a0targets, thus inhibiting the\u00a0sonic hedgehog (SHH) signaling pathway. In brief, our findings demonstrated that TM effectively inhibited the activities of PCa cells by suppressing the\u00a0SHH signaling pathway and provided a potential new agent for the treatment of PCa.<\/jats:p>","DOI":"10.1186\/s10020-025-01080-1","type":"journal-article","created":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T14:24:20Z","timestamp":1738160660000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Tegaserod maleate exerts anti-tumor effects on prostate cancer via repressing sonic hedgehog signaling pathway"],"prefix":"10.1186","volume":"31","author":[{"given":"Maoping","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengdong","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaying","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang-Zi","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dacai","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingkun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe-Sheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ninghan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanghui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1162-8077","authenticated-orcid":false,"given":"Shan-Chao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,29]]},"reference":[{"issue":"7","key":"1080_CR1","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/nrm3598","volume":"14","author":"J Briscoe","year":"2013","unstructured":"Briscoe J, Th\u00e9rond PP. The mechanisms of Hedgehog signalling and its roles in development and disease. Nat Rev Mol Cell Biol. 2013;14(7):416\u201329.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1080_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2023.100962","volume":"68","author":"M Cai","year":"2023","unstructured":"Cai M, et al. Current therapy and drug resistance in metastatic castration-resistant prostate cancer. Drug Resist Updat. 2023;68: 100962.","journal-title":"Drug Resist Updat"},{"issue":"3","key":"1080_CR3","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/S0092-8674(00)81374-4","volume":"87","author":"Y Chen","year":"1996","unstructured":"Chen Y, Struhl G. Dual roles for patched in sequestering and transducing Hedgehog. Cell. 1996;87(3):553\u201363.","journal-title":"Cell"},{"issue":"34","key":"1080_CR4","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2202821119","volume":"119","author":"L Chen","year":"2022","unstructured":"Chen L, et al. O-GlcNAcylation promotes cerebellum development and medulloblastoma oncogenesis via SHH signaling. Proc Natl Acad Sci U S A. 2022;119(34): e2202821119.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"1080_CR5","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.eururo.2020.09.046","volume":"79","author":"P Cornford","year":"2021","unstructured":"Cornford P, et al. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Part II-2020 Update: treatment of relapsing and metastatic prostate cancer. Eur Urol. 2021;79(2):263\u201382.","journal-title":"Eur Urol"},{"issue":"4","key":"1080_CR6","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s00018-005-5389-4","volume":"63","author":"S Datta","year":"2006","unstructured":"Datta S, Datta MW. Sonic Hedgehog signaling in advanced prostate cancer. Cell Mol Life Sci. 2006;63(4):435\u201348.","journal-title":"Cell Mol Life Sci"},{"key":"1080_CR7","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.canlet.2018.10.021","volume":"442","author":"P Gupta","year":"2019","unstructured":"Gupta P, et al. HER2-mediated GLI2 stabilization promotes anoikis resistance and metastasis of breast cancer cells. Cancer Lett. 2019;442:68\u201381.","journal-title":"Cancer Lett"},{"issue":"6","key":"1080_CR8","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1158\/0008-5472.CAN-21-4249","volume":"83","author":"YG Hong","year":"2023","unstructured":"Hong YG, et al. The RNA m6A Reader YTHDF1 is required for acute myeloid leukemia progression. Cancer Res. 2023;83(6):845\u201360.","journal-title":"Cancer Res"},{"key":"1080_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2021.06.006","volume":"518","author":"A Jamroze","year":"2021","unstructured":"Jamroze A, Chatta G, Tang DG. Androgen receptor (AR) heterogeneity in prostate cancer and therapy resistance. Cancer Lett. 2021;518:1\u20139.","journal-title":"Cancer Lett"},{"key":"1080_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21030758","author":"KS Jeng","year":"2020","unstructured":"Jeng KS, Chang CF, Lin SS. Sonic hedgehog signaling in organogenesis, tumors, and tumor microenvironments. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21030758.","journal-title":"Int J Mol Sci"},{"key":"1080_CR11","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.semcancer.2021.04.003","volume":"85","author":"J Jiang","year":"2022","unstructured":"Jiang J. Hedgehog signaling mechanism and role in cancer. Semin Cancer Biol. 2022;85:107\u201322.","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"1080_CR12","doi-asserted-by":"publisher","first-page":"92","DOI":"10.2174\/1574892816666211013113841","volume":"17","author":"P Kriplani","year":"2022","unstructured":"Kriplani P, Guarve K. Eudragit, a nifty polymer for anticancer preparations: a patent review. Recent Pat Anticancer Drug Discov. 2022;17(1):92\u2013101.","journal-title":"Recent Pat Anticancer Drug Discov"},{"issue":"4","key":"1080_CR13","doi-asserted-by":"publisher","first-page":"e682","DOI":"10.1016\/j.cgh.2021.05.040","volume":"20","author":"BE Lacy","year":"2022","unstructured":"Lacy BE, Brenner DM, Chey WD. Re-evaluation of the cardiovascular safety profile of tegaserod: a review of the clinical data. Clin Gastroenterol Hepatol. 2022;20(4):e682\u201395.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1080_CR14","first-page":"5320421","volume":"2022","author":"X Li","year":"2022","unstructured":"Li X, et al. Tegaserod maleate inhibits breast cancer progression and enhances the sensitivity of immunotherapy. J Oncol. 2022a;2022:5320421.","journal-title":"J Oncol"},{"issue":"16","key":"1080_CR15","doi-asserted-by":"publisher","first-page":"6145","DOI":"10.7150\/ijbs.75063","volume":"18","author":"P Li","year":"2022","unstructured":"Li P, et al. ELK1-mediated YTHDF1 drives prostate cancer progression by facilitating the translation of Polo-like kinase 1 in an m6A dependent manner. Int J Biol Sci. 2022b;18(16):6145\u201362.","journal-title":"Int J Biol Sci"},{"issue":"1","key":"1080_CR16","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13046-020-1539-7","volume":"39","author":"W Liu","year":"2020","unstructured":"Liu W, et al. Repurposing the serotonin agonist Tegaserod as an anticancer agent in melanoma: molecular mechanisms and clinical implications. J Exp Clin Cancer Res. 2020;39(1):38.","journal-title":"J Exp Clin Cancer Res"},{"key":"1080_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.215927","volume":"550","author":"J Liu","year":"2022","unstructured":"Liu J, et al. Prostate cancer treatment\u2014China\u2019s perspective. Cancer Lett. 2022;550: 215927.","journal-title":"Cancer Lett"},{"issue":"1","key":"1080_CR18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2478\/jtim-2022-0009","volume":"10","author":"D Lu","year":"2022","unstructured":"Lu D, Gao Y. Immune checkpoint inhibitor-related endocrinopathies. J Transl Int Med. 2022;10(1):9\u201314.","journal-title":"J Transl Int Med"},{"key":"1080_CR19","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.canlet.2021.08.033","volume":"523","author":"V Ruiz de Porras","year":"2021","unstructured":"Ruiz de Porras V, Font A, Aytes A. Chemotherapy in metastatic castration-resistant prostate cancer: current scenario and future perspectives. Cancer Lett. 2021;523:162\u20139.","journal-title":"Cancer Lett"},{"issue":"10","key":"1080_CR20","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1016\/j.cgh.2022.01.024","volume":"20","author":"GS Sayuk","year":"2022","unstructured":"Sayuk GS, Tack J. Tegaserod: what\u2019s old is new again. Clin Gastroenterol Hepatol. 2022;20(10):2175-2184.e19.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"1080_CR21","doi-asserted-by":"publisher","first-page":"491","DOI":"10.2165\/00003495-199958030-00013","volume":"58","author":"LJ Scott","year":"1999","unstructured":"Scott LJ, Perry CM. Tegaserod. Drugs. 1999;58(3):491\u20136; discussion 497-8.","journal-title":"Drugs"},{"issue":"1","key":"1080_CR22","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, et al. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7\u201333.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"1080_CR23","doi-asserted-by":"publisher","first-page":"143","DOI":"10.2478\/jtim-2021-0010","volume":"9","author":"R Tulsi","year":"2021","unstructured":"Tulsi R, et al. Metastasis of duodenal adenocarcinoma to the urinary bladder presenting as hematuria. J Transl Int Med. 2021;9(2):143\u20135.","journal-title":"J Transl Int Med"},{"key":"1080_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14153592","author":"Z Wang","year":"2022","unstructured":"Wang Z, et al. Tegaserod maleate suppresses the growth of gastric cancer in vivo and in vitro by targeting MEK1\/2. Cancers (Basel). 2022. https:\/\/doi.org\/10.3390\/cancers14153592.","journal-title":"Cancers (Basel)"},{"key":"1080_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/s10495-023-01885-7","author":"Y Wang","year":"2023","unstructured":"Wang Y, Jin P, Wang X. N(6)-methyladenosine regulator YTHDF1 represses the CD8 + T cell-mediated antitumor immunity and ferroptosis in prostate cancer via m(6)A\/PD-L1 manner. Apoptosis. 2023. https:\/\/doi.org\/10.1007\/s10495-023-01885-7.","journal-title":"Apoptosis"},{"issue":"5","key":"1080_CR26","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1097\/CM9.0000000000002108","volume":"135","author":"C Xia","year":"2022","unstructured":"Xia C, et al. Cancer statistics in China and United States, 2022: profiles, trends, and determinants. Chin Med J (Engl). 2022;135(5):584\u201390.","journal-title":"Chin Med J (Engl)"},{"key":"1080_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.678967","volume":"9","author":"ZM Xiao","year":"2021","unstructured":"Xiao ZM, et al. SMARCC1 suppresses tumor progression by inhibiting the PI3K\/AKT signaling pathway in prostate cancer. Front Cell Dev Biol. 2021;9: 678967.","journal-title":"Front Cell Dev Biol"},{"key":"1080_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113566","volume":"154","author":"X Xie","year":"2022","unstructured":"Xie X, et al. Tegaserod maleate exhibits antileukemic activity by targeting TRPM8. Biomed Pharmacother. 2022a;154: 113566.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"1080_CR29","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s12943-022-01630-9","volume":"21","author":"T Xie","year":"2022","unstructured":"Xie T, et al. CircSMARCC1 facilitates tumor progression by disrupting the crosstalk between prostate cancer cells and tumor-associated macrophages via miR-1322\/CCL20\/CCR6 signaling. Mol Cancer. 2022b;21(1):173.","journal-title":"Mol Cancer"},{"key":"1080_CR30","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.canlet.2021.06.010","volume":"519","author":"Y Yamada","year":"2021","unstructured":"Yamada Y, Beltran H. The treatment landscape of metastatic prostate cancer. Cancer Lett. 2021;519:20\u20139.","journal-title":"Cancer Lett"},{"issue":"1","key":"1080_CR31","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1038\/s41467-023-37100-z","volume":"14","author":"S Yan","year":"2023","unstructured":"Yan S, et al. Adipocyte YTH N(6)-methyladenosine RNA-binding protein 1 protects against obesity by promoting white adipose tissue beiging in male mice. Nat Commun. 2023;14(1):1379.","journal-title":"Nat Commun"},{"issue":"1","key":"1080_CR32","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12943-021-01480-x","volume":"21","author":"YZ Yu","year":"2022","unstructured":"Yu YZ, et al. Hsa_circ_0003258 promotes prostate cancer metastasis by complexing with IGF2BP3 and sponging miR-653-5p. Mol Cancer. 2022;21(1):12.","journal-title":"Mol Cancer"},{"issue":"4","key":"1080_CR33","doi-asserted-by":"publisher","first-page":"225","DOI":"10.2478\/jtim-2021-0036","volume":"9","author":"X Ze","year":"2021","unstructured":"Ze X, Zou W, Li Z. Translational research in anti-pancreatic fibrosis drug discovery and development. J Transl Int Med. 2021;9(4):225\u20137.","journal-title":"J Transl Int Med"},{"issue":"4","key":"1080_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111530","volume":"41","author":"ZW Zhang","year":"2022","unstructured":"Zhang ZW, et al. METTL3 regulates m(6)A methylation of PTCH1 and GLI2 in Sonic hedgehog signaling to promote tumor progression in SHH-medulloblastoma. Cell Rep. 2022;41(4): 111530.","journal-title":"Cell Rep"}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-025-01080-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10020-025-01080-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-025-01080-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T14:24:31Z","timestamp":1738160671000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.1186\/s10020-025-01080-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,29]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1080"],"URL":"https:\/\/doi.org\/10.1186\/s10020-025-01080-1","relation":{},"ISSN":["1528-3658"],"issn-type":[{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,29]]},"assertion":[{"value":"13 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal study was approved by the Ethics Committee of Zhanjiang Centre Hospital (approval number: ZJDY2023-61).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"30"}}